LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Rapid AST: Possibility of inferring resistance mechanisms with complex phenotypes.

    Ligero-López, J / Falces-Romero, I / Aranda-Díaz, A / García-Ballesteros, D / García-Rodríguez, J / Cendejas-Bueno, E

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

    2023  Volume 37, Issue 1, Page(s) 88–92

    Abstract: The new automated systems designed for rapid performance of AST have significantly reduced the response time for susceptibility testing of microorganisms causing bacteremia and sepsis. The Accelerate Pheno® system (AAC) is one such system. Our objective ... ...

    Abstract The new automated systems designed for rapid performance of AST have significantly reduced the response time for susceptibility testing of microorganisms causing bacteremia and sepsis. The Accelerate Pheno® system (AAC) is one such system. Our objective for this study was to determine whether the AAC system is capable of providing an accurate susceptibility profile to infer resistance mechanisms in different carbapenemase-producing isolates when compared to the MicroScan WalkAway System (MWS). Disk diffusion method was also performed on all isolates as a reference method. Additionally, we compared the results obtained with the routine AST production system. We selected 19 isolates from the cryobank of the Microbiology department, all of which were carbapenemase-producing gram-negative bacilli. AAC was able to identify and infer the resistance of a total of 10 isolates, with an EA and CA of 84.2% for meropenem and 88.2% and 64.7% for ertapenem EA and CA, respectively. If we consider the disk diffusion technique, the CA was 57.9% and 76.5% for meropenem and ertapenem. However, in the presence of carbapenemases, AAC was not able to provide adequate MICs or infer the resistance mechanisms of the isolates accurately. Further studies with a larger number of isolates, including the new antibiotics ceftolozane/tazobactam and ceftazidime/avibactam, are needed for a more comprehensive comparison.
    MeSH term(s) Humans ; Meropenem ; Ertapenem ; Anti-Bacterial Agents/pharmacology ; Gram-Negative Bacteria ; beta-Lactamases/genetics ; Microbial Sensitivity Tests ; Pseudomonas aeruginosa
    Chemical Substances Meropenem (FV9J3JU8B1) ; Ertapenem (G32F6EID2H) ; Anti-Bacterial Agents ; beta-Lactamases (EC 3.5.2.6)
    Language English
    Publishing date 2023-11-08
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 1018135-0
    ISSN 1988-9518 ; 0214-3429
    ISSN (online) 1988-9518
    ISSN 0214-3429
    DOI 10.37201/req/043.2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Evaluation of MSP96, MBT Biotarget™ 96 and AnchorChip™ 600/96 MALDI-TOF MS target plates for direct identification of positive blood cultures.

    Navarro-Carrera, Paula / Aranda-Diaz, Alfonso / García-Ballesteros, Diana / Cacho-Calvo, Juana / García-Rodríguez, Julio / Cendejas-Bueno, Emilio

    Journal of microbiological methods

    2023  Volume 211, Page(s) 106789

    Abstract: The objective of the study was to compare the diagnostic performances of three Bruker MALDI-TOF MS target plates. A combination of two or three targets results in an increase of the identification percentage, especially in problem isolates as gram- ... ...

    Abstract The objective of the study was to compare the diagnostic performances of three Bruker MALDI-TOF MS target plates. A combination of two or three targets results in an increase of the identification percentage, especially in problem isolates as gram-positive cocci and yeast.
    MeSH term(s) Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods ; Blood Culture
    Language English
    Publishing date 2023-07-20
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 604916-3
    ISSN 1872-8359 ; 0167-7012
    ISSN (online) 1872-8359
    ISSN 0167-7012
    DOI 10.1016/j.mimet.2023.106789
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Evaluation of a lateral flow immunoassay to detect CTX-M extended-spectrum β-lactamases (ESBL) directly from positive blood cultures for its potential use in Antimicrobial Stewardship programs.

    Cendejas-Bueno, E / Romero-Gómez, M P / Falces-Romero, I / Aranda-Diaz, A / García-Ballesteros, D / Mingorance, J / García-Rodríguez, J

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

    2022  Volume 35, Issue 3, Page(s) 284–287

    Abstract: Objective: Bloodstream infections (BSI) caused by extended-spectrum beta-lactamases Enterobacteriaceae (ESBL-E) are associated with high rates of treatment failure and increased mortality, especially when appropriate antimicrobial therapy is delayed. ... ...

    Abstract Objective: Bloodstream infections (BSI) caused by extended-spectrum beta-lactamases Enterobacteriaceae (ESBL-E) are associated with high rates of treatment failure and increased mortality, especially when appropriate antimicrobial therapy is delayed. Our aim was to evaluate the anticipation of ESBLs detection and the potential improvement of the time response of the Vitek 2 System (BioMérieux; France).
    Methods: We compared this lateral flow immunoassay when used directly on fluid from positive blood cultures to the VITEK2 AST system. We evaluated 80 isolates, 61 tested directly on fluid from positive blood cultures and 19 tested on fluid from blood cultures spiked with known ESBL positive and negative organisms.
    Results: The concordance between the CTX-LFIA and the reference method (Vitek 2) had a Cohen´s Kappa coefficient of 0.97, indicating a particularly good correlation between both compared methods.
    Conclusions: This lateral flow immunoassay can be more rapid than the Vitek 2 for earlier presumptive identification of CTX-M ESBLs and can be useful to anticipate results and the adjustment of antimicrobial therapy.
    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship ; Blood Culture ; Enterobacteriaceae Infections/drug therapy ; Humans ; Immunoassay ; Microbial Sensitivity Tests ; beta-Lactamases
    Chemical Substances Anti-Bacterial Agents ; beta-Lactamases (EC 3.5.2.6)
    Language English
    Publishing date 2022-03-31
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 1018135-0
    ISSN 1988-9518 ; 0214-3429
    ISSN (online) 1988-9518
    ISSN 0214-3429
    DOI 10.37201/req/164.2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top